| 研究開始時の研究の概要 |
In this project, novel, clinically-translatable, personalized anticancer vaccines will be developed using messenger RNA (mRNA) and lipid nanoparticles (LNPs) technologies. LNPs that target the antigen-presenting cells will be used to deliver mRNAs encoding neoantigens to elicit anticancer immunity.
|
